Finance

Beta
Lists
LBRX:NASDAQ
LB Pharmaceuticals Inc
$33.43
+4.83%
(+1.54) 1D
$33.48
+0.15% (+0.050)
After hours
Closed: Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LBRX...
Open
$32.08
High
$34.00
Low
$31.82
Mkt. cap
958.66M
Avg. vol.
280.12K
Volume
406.03K
52-wk high
$34.00
52-wk low
$13.40
EPS
-$1.49
Shares outstanding
28.68M
No. of employees
35
Open
$32.08
High
$34.00
Low
$31.82
Mkt. cap
958.66M
Avg. vol.
280.12K
Volume
406.03K
52-wk high
$34.00
52-wk low
$13.40
EPS
-$1.49
Shares outstanding
28.68M
No. of employees
35
News stories
From sources across the web
About LB Pharmaceuticals Inc
CEO-
Employees35
Founded2015
Headquarters-
SectorPharmaceutical industry
Websitelbpharma.us
Analyst ratings
Based on 5 analysts giving stock ratings to LBRX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for LBRX in the last 3 months.
Highest
Current $33.43
$78.00 (+133.32%)
Average
$48.20 (+44.18%)
Lowest
$36.00 (+7.69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$45.00
+34.6%
06/25/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
$36.00
+7.7%
06/11/2026
Kaveri Pohlman
Clear Street
Buy
Initiated
$45.00
+34.6%
05/26/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
$37.00
+10.7%
05/18/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$78.00
+133.3%
05/13/2026
Paul Matteis
Stifel Nicolaus
Buy
Reiterated
$40.00
+19.7%
03/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.42M
2.42M
7.98M
14.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.01M
2.83M
4.99M
7.46M
Operating expense
6.43M
5.25M
12.97M
22.00M
Total operating expenses
6.43M
5.25M
12.97M
22.00M
Operating income
-6.43M
-5.25M
-12.97M
-22.00M
Other non operating income
768.00K
983.00K
-401.00K
200.00K
EBT including unusual items
-5.31M
-3.56M
-11.47M
-19.05M
EBT excluding unusual items
-5.42M
-3.56M
-10.57M
-18.95M
Income tax expense
-
-
1.00K
-
Effective tax rate
-
-
-0.01%
-
Other operating expenses
-
-
-
-
Net income
-5.31M
-3.56M
-11.47M
-19.05M
Net profit margin
-
-
-
-
Earnings per share
-
-0.61
-0.45
-0.67
Interest and investment income
236.00K
707.00K
2.80M
2.85M
Interest expense
-
-
-
-
Net interest expenses
236.00K
707.00K
2.80M
2.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.35M
-5.16M
-12.88M
-21.92M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer